Hab Pharmaceuticals & Research Ltd, a prominent drug firm, has its significant presence in the market. Established in the mid-90s, the firm quickly developed as the major player, concentrating on developing premium affordable medications. The company's developmental activities center on multiple therapeutic areas, including circulatory diseases, di